Spotlight on Pfizer: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.

Looking at options history for Pfizer PFE we detected 18 trades.

If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish.

From the overall spotted trades, 7 are puts, for a total amount of $342,961 and 11, calls, for a total amount of $463,767.

Predicted Price Range

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $35.0 for Pfizer over the last 3 months.

Volume & Open Interest Development

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pfizer's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pfizer's substantial trades, within a strike price spectrum from $15.0 to $35.0 over the preceding 30 days.

Pfizer Option Activity Analysis: Last 30 Days

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
PFE PUT SWEEP BULLISH 06/20/25 $3.9 $3.8 $3.8 $30.00 $113.6K 3.1K 349
PFE CALL SWEEP BEARISH 01/16/26 $2.92 $2.91 $2.91 $30.00 $92.4K 31.7K 819
PFE PUT SWEEP BULLISH 06/14/24 $0.76 $0.71 $0.71 $28.50 $55.4K 11.8K 1.0K
PFE CALL TRADE BEARISH 01/16/26 $2.94 $2.91 $2.91 $30.00 $54.4K 31.7K 1.0K
PFE PUT SWEEP BULLISH 07/19/24 $0.77 $0.76 $0.76 $28.00 $53.8K 12.4K 1.1K

About Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Having examined the options trading patterns of Pfizer, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Where Is Pfizer Standing Right Now?

  • With a volume of 17,018,916, the price of PFE is down -0.94% at $28.31.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 50 days.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs
Date of Trade
Strike Price
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!